Tyndall Mark Anthony
Insider CIK 1944622 · MNK EVP & Chief Legal Offi & Secre
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NONE Keenova Therapeutics plc | A Award deriv | 2026-02-25 | 2026-02-26 | 51,794 | — | $0 | 97,825 | SEC↗ |
| NONE Keenova Therapeutics plc | M Exercise deriv | 2026-01-01 | 2026-01-05 | 6,576 | — | $0 | 46,031 | SEC↗ |
| NONE Keenova Therapeutics plc | F Tax w/h | 2026-01-01 | 2026-01-05 | 2,107 | — | $0 | 8,167 | SEC↗ |
| NONE Keenova Therapeutics plc | M Exercise | 2026-01-01 | 2026-01-05 | 6,576 | — | $0 | 10,274 | SEC↗ |
| NONE Mallinckrodt plc | A Award deriv | 2025-07-31 | 2025-08-04 | 32,828 | — | $0 | 43,771 | SEC↗ |
| NONE Mallinckrodt plc | M Exercise deriv | 2025-01-01 | 2025-01-02 | 5,470 | — | $0 | 10,943 | SEC↗ |
| NONE Mallinckrodt plc | F Tax w/h | 2025-01-01 | 2025-01-02 | 1,772 | — | $0 | 3,698 | SEC↗ |
| NONE Mallinckrodt plc | M Exercise | 2025-01-01 | 2025-01-02 | 5,470 | — | $0 | 5,470 | SEC↗ |
| NONE Mallinckrodt plc | A Award deriv | 2024-02-02 | 2024-02-06 | 16,413 | — | $0 | 16,413 | SEC↗ |
| MNKTQ Mallinckrodt plc | D To issuer | 2023-11-14 | 2023-11-16 | 63,802 | — | $0 | 0 | SEC↗ |
| MNK Mallinckrodt plc | F Tax w/h | 2023-08-17 | 2023-08-18 | 11,289 | $0.69 | $7.8K | 63,802 | SEC↗ |
| MNK Mallinckrodt plc | D To issuer deriv | 2023-06-30 | 2023-07-05 | 114,402 | — | $0 | 0 | SEC↗ |
| MNK Mallinckrodt plc | A Award deriv | 2023-04-03 | 2023-04-05 | 114,402 | — | $0 | 114,402 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2022-12-14 | 2022-12-22 | 75,091 | — | $0 | 75,091 | SEC↗ |